Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Pediatric acute myeloid leukemia].
Moritake H. Moritake H. Rinsho Ketsueki. 2024;65(9):928-936. doi: 10.11406/rinketsu.65.928. Rinsho Ketsueki. 2024. PMID: 39358292 Review. Japanese.
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.
Kato S, Nakashima K, Yamato G, Saito S, Taneyama Y, Yamamoto N, Miyamura T, Kato K, Sato Y, Yamada A, Kamiya T, Nishikawa T, Uemura S, Tomizawa D, Moritake H, Terui K, Taga T, Hasegawa D. Kato S, et al. Among authors: moritake h. Pediatr Blood Cancer. 2024 Oct;71(10):e31244. doi: 10.1002/pbc.31244. Epub 2024 Aug 4. Pediatr Blood Cancer. 2024. PMID: 39099137
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial.
Arima M, Inoue H, Misumi A, Tsukamoto S, Matsushita I, Araki S, Ohta M, Takahashi K, Imazato M, Goto T, Aoki Y, Tagawa K, Hirose M, Fujita Y, Yoshida N, Nakao S, Kondo H, Kusuhara K, Kimura K, Hasegawa S, Ikeda Y, Kodama Y, Moritake H, Ochiai M, Ohga S, Kishimoto J, Todaka K, Ieiri I, Sonoda KH. Arima M, et al. Among authors: moritake h. Jpn J Ophthalmol. 2024 Sep;68(5):490-499. doi: 10.1007/s10384-024-01100-3. Epub 2024 Jul 26. Jpn J Ophthalmol. 2024. PMID: 39060675 Clinical Trial.
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.
Iyoda S, Yoshida K, Shoji K, Ito N, Tanaka M, Nannya Y, Yamato G, Tsujimoto S, Shiba N, Hayashi Y, Shiozawa Y, Shiraishi Y, Chiba K, Okada A, Tanaka H, Miyano S, Koga Y, Goto H, Moritake H, Terui K, Ito E, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Takita J, Nishikori M, Adachi S, Ogawa S, Matsuo H. Iyoda S, et al. Among authors: moritake h. Leukemia. 2024 Jul;38(7):1609-1612. doi: 10.1038/s41375-024-02244-4. Epub 2024 Apr 18. Leukemia. 2024. PMID: 38632314 No abstract available.
Early hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis in a regional treatment network in Japan.
Ishimura M, Eguchi K, Sonoda M, Tanaka T, Shiraishi A, Sakai Y, Yasumi T, Miyamoto T, Voskoboinik I, Hashimoto K, Matsumoto S, Ozono S, Moritake H, Takada H, Ohga S. Ishimura M, et al. Among authors: moritake h. Int J Hematol. 2024 May;119(5):592-602. doi: 10.1007/s12185-024-03721-3. Epub 2024 Mar 20. Int J Hematol. 2024. PMID: 38507116
120 results